South Korea Angioplasty Balloons Market Size, Share, and COVID-19 Impact Analysis, By Product (Normal Balloons and Drug Coated Balloons), By Application (Coronary and Peripheral), By End Use (Ambulatory Surgical Centers, Hospitals, and Cath Labs), and South Korea Angioplasty Balloons Market Insights, Industry Trend, Forecasts to 2035

  South Korea Angioplasty Balloons Market Insights Forecasts to 2035

• The South Korea Angioplasty Balloons Market Size Was Estimated at USD 80.3 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 4.11% from 2025 to 2035
• The South Korea Angioplasty Balloons Market Size is Expected to Reach USD 125.0 Million by 2035

According to a Research Report Published by Spherical Insights & Consulting, The South Korea Angioplasty Balloons Market Size is anticipated to Reach USD 125.0 Million by 2035, Growing at a CAGR of 4.11% from 2025 to 2035. An aging population and the increasing prevalence of cardiovascular illnesses, especially coronary artery disease, are the main factors propelling the market.

Market Overview

The industry that develops, produces, and distributes medical devices used in angioplasty operations to treat blocked or narrowed blood arteries is included in the market for angioplasty balloons. In order to widen arteries, restore blood flow, and treat diseases including peripheral artery disease and coronary artery disease, these devices, mostly balloon catheters, are essential. Compared to open surgery, angioplasty balloons minimize bodily harm by treating clogged or constricted arteries through tiny incisions. Compared to standard surgery, balloon angioplasty usually results in shorter hospital stays and a quicker return to normal activities. Minimally invasive procedures like angioplasty have shorter recovery times and a lower risk of problems than open heart surgery, and they are becoming more and more popular. To increase access to healthcare and raise the standard of cardiovascular treatment, governments are enacting changes. This includes support for the use of minimally invasive procedures and more money for the study and creation of novel angioplasty technology, like drug-eluting balloons.

Report Coverage

This research report categorizes the market for South Korea angioplasty balloons market based on various segments and regions forecasts revenue growth, and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea angioplasty balloons market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment South Korea angioplasty balloons market.

Driving Factors

The rising prevalence of cardiovascular diseases, growing elderly population, and increasing adoption of minimally invasive procedures. Advancements in balloon technologies, such as drug-coated and high-pressure balloons, enhance treatment outcomes and further fuel demand. Expanding health insurance coverage, and growing awareness of early diagnosis and treatment of heart conditions are contributing significantly to market growth. The shift toward outpatient care also supports market expansion.

Restraining Factors

High costs associated with advanced devices, such as drug-coated balloons, limit accessibility, especially in cost-sensitive settings. Stringent regulatory approval processes can delay market entry for new products.

Market Segmentation

The South Korea angioplasty balloons market share is classified into product, application, and end-use.

• The normal balloons segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea angioplasty balloons market is segmented by product into normal balloons and drug coated balloons. Among these, the normal balloons segment held a significant share in 2024 and is expected to grow at a substantial CAGR during the forecast period. Lower cost, widespread availability, and established clinical efficacy. Their continued adoption of routine procedures and growing cardiovascular disease prevalence.

• The coronary segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea angioplasty balloons market is segmented by application into coronary and peripheral. Among these, the coronary segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. The high prevalence of coronary artery disease and increasing demand for minimally invasive cardiac procedures. Advancements in balloon technology and growing healthcare investments.

• The ambulatory surgical centers segment dominated the share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea angioplasty balloons market is segmented by end-use into ambulatory surgical centers, hospitals, and cath labs. Among these, the ambulatory surgical centers segment dominated the share in 2024 and is expected to grow at a significant CAGR during the forecast period. Their cost-effective procedures, shorter patient recovery times, and increasing preference for outpatient interventions. Technological advancements and healthcare policy support for minimally invasive treatments.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea angioplasty balloons market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the companies' current news and developments, including product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Genoss
• Korea Medical Devices Co., Ltd.
• Osstem Implant Co., Ltd.
• Goodgene Inc.
• Aprogen Inc.
• Korea Interventional Radiology Medical Co.
• Hugel, Inc.
• Vatech Co., Ltd.
• Mediwhale Co., Ltd.
• CGBio Co., Ltd.
• Others

Recent Developments:

• In November 2023, GlobalData’s Market Model methodology determined that the leading player in the ptca balloon catheters market in South Korea was Boston Scientific followed by Shockwave Medical, Medtronic, B. Braun Melsungen, Koninklijke Philips, Terumo, Microport Scientific, Biotronik SE, Teleflex, Meril Life Sciences, OrbusNeich and Abbott Laboratories.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea angioplasty balloons market based on the below-mentioned segments:

South Korea Angioplasty Balloons Market, By Product

• Normal Balloons
• Drug Coated Balloons

South Korea Angioplasty Balloons Market, By Application

• Coronary
• Peripheral

South Korea Angioplasty Balloons Market, By End Use

• Ambulatory Surgical Centers
• Hospitals
• Cath Labs